Cargando…
Safe Blood Donation from Donors Using Antihypertensive Medication. A Multi-Center Retrospective Quality Study from South-East Norway
PURPOSE: In Norway, blood donors using antihypertensive medication were deferred until 2015. Following revision of the national directive, these donors could be allowed, providing stable dose for at least 3 months, adequate blood pressure control and no adverse effects caused by the therapy. The new...
Autores principales: | Johnsen, Kathrine M Neuman, Magnussen, Karin, Erstad, Christian, Bhatti, Sadaf Nabi, Nissen-Meyer, Lise Sofie H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164375/ https://www.ncbi.nlm.nih.gov/pubmed/37163174 http://dx.doi.org/10.2147/JBM.S390609 |
Ejemplares similares
-
Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021
por: Hvalryg, Marte, et al.
Publicado: (2021) -
Can Older Adults Safely Donate Kidneys? Can Older Adults Safely Donate Kidneys?
Publicado: (2018) -
Safe Long-Term Outcome After Kidney Donation in Older Donors: A Single-Center Experience
por: Schuster, Antonia, et al.
Publicado: (2020) -
Safely Expanding the Liver Donor Pool by Utilization of Organs from Donation after Circulatory Death with Comparable Results to Donation After Brain Death, a Large Single-Center Experience
por: Limkemann, Ashley J., et al.
Publicado: (2022) -
On harm thresholds and living organ donation: must the living donor benefit, on balance, from his donation?
por: Williams, Nicola Jane
Publicado: (2017)